RE: Superb - Proactive Interview!26 Mar 2020 14:03
Tiziana Life Sciences plc to expedite development of TZLS-501 for COVID-19Tiziana's anti-IL-6R mAb binds to both the membrane-bound and soluble forms of IL-6R and rapidly depletes circulating levels of IL-6 in the blood.
By - Medical Dialogues Bureau
Published On 2020-03-13 05:45 GMT | Update On 2020-03-13 07:39 GMT